Production of tallow derivatives for use in pharmaceuticals - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document discusses the use of tallow derivatives in medicinal products or during their manufacturing process. It gives recommendations for the manufacturing conditions of pharmaceutical grade tallow derivatives.
Keywords: Tallow, magnisum stearate, glycerol, polysorbates, bovine spongiform encephalopathy (BSE), transmissible spongiform encephalopathies (TSE)